Eleftherios Paul Mamounas

Learn More
Autologous fat transplantation was initially performed by plastic surgeons for improving facial and body contour depressions and scars. There has been long-standing interest in breast augmentation for cosmetic purposes and for the filling of defects from partial breast resection for breast cancer. In the 1980s, autologous fat transplantation for breast(More)
The National Comprehensive Cancer Network (NCCN) first published the NCCN Breast Cancer Treatment Guidelines in 1996. The Guidelines address the treatment of all stages of breast cancer across the spectrum of patient care and have been updated yearly. Adjuvant therapy for breast cancer has undergone an especially rapid evolution over the past few years.(More)
Neoadjuvant chemotherapy has the advantage of converting unresectable breast tumors to resectable tumors and allowing more conservative surgery in some mastectomy candidates. Chemotherapy agents, including taxanes, which are recommended in the adjuvant setting, are also considered in the neoadjuvant setting. Here, we review studies of nab-paclitaxel as a(More)
The idea of using preoperative or neoadjuvant chemotherapy in patients with operable breast cancer originated from experimental and clinical observations as well as theoretical hypotheses on tumor cell growth and dissemination. Initially, nonrandomized studies demonstrated considerable rates of clinical tumor response, low rates of pathologic complete(More)
Introduction: Previous mastectomy remains a contraindication to SLNB as normal drainage patterns of the breast can be disturbed. Patients diagnosed with DCIS on core biopsy and later found to have microinvasive or invasive carcinoma at the time of mastectomy are deprived of the opportunity for SLNB and need to undergo axillary dissection. We explored the(More)
  • 1